Abstract
These studies investigate how interactions between the BCR and FcγRIIB affect B lymphocyte stimulator (BLyS) receptor expression and signaling. Previous studies showed that BCR ligation up-regulates BLyS binding capacity in mature B cells, reflecting increased BLyS receptor levels. Here we show that FcγRIIB coaggregation dampens BCR-induced BLyS receptor up-regulation. This cross-regulation requires BCR and FcγRIIB coligation, and optimal action relies on the Src-homology-2 (SH2)-containing inositol 5 phosphase-1 (SHIP1). Subsequent to FcγRIIB/BCR coaggregation, the survival promoting actions of BLyS are attenuated, reflecting reduced BLyS receptor signaling capacity in terms of Pim 2 maintenance, noncanonical NF-κB activation, and Bcl-xL levels. These findings link the negative regulatory functions of FcγRIIB with BLyS-mediated B-cell survival. © 2009 by The American Society of Hematoloty.
Cite
CITATION STYLE
Crowley, J. E., Stadanlick, J. E., Cambier, J. C., & Cancro, M. P. (2009). Fc{gamma}RIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation. Blood, 113(7), 1464–1473. https://doi.org/10.1182/blood-2008-02-138651
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.